Congratulations WhiteLab Genomics on being recognized by Sifted as one of the 50 fastest-growing startups in France during 2024! ?? WhiteLab Genomics stands out in genomic medicine by focusing on the atomic-level optimization of interactions between genomic therapy vectors and transmembrane proteins. By applying structural biology and drug design principles, WhiteLab pioneers innovative methods that elevate R&D across diverse therapeutic areas. Their approach blends advanced machine learning with deep expertise in ligand-target interactions. Through collaborations with industry leaders such as Debiopharm, Sanofi, Siren Biotechnology, other major pharmaceutical companies, and top academic institutions, WhiteLab accelerates and de-risks R&D, driving genomic medicine to new frontiers. Congrats team! We are proud to work with you ?? CC: David Del Bourgo Julien Cottineau Lucia Cinque Timothé CYNOBER (Pharm D.) Nathan Lee Sarah Cordelle Natasha Liu Maud Thouverez Abiramy Sinnadurai Rayhan Ullah Dina Zielinski
Klover Communications
公共关系和沟通服务
Irvine,CA 317 位关注者
PR & Communications for Pioneers in Life Science and Healthcare - Straightforward Storytelling That Gets Results
关于我们
We are a trusted partner to change-maker VCs, startups, publicly traded companies, non-profits, and innovators who are shaping the future. As a boutique agency, we bring together specialists from diverse fields, including former journalists, PhD scientists, and engineers. We founded our firm after recognizing the unique challenges and opportunities in life sciences and healthcare. By leveraging unique competencies, we ensure our clients receive expert solutions tailored to their needs.
- 网站
-
https://www.klovercommunications.com
Klover Communications的外部链接
- 所属行业
- 公共关系和沟通服务
- 规模
- 2-10 人
- 总部
- Irvine,CA
- 类型
- 自有
- 创立
- 2013
- 领域
- Marketing、Public Relations、Event Planning和Research
地点
-
主要
US,CA,Irvine
动态
-
Proud moment! Is that Celmatix we see on the Nasdaq screen in Times Square ?? ? Yes it is! We love working with the some of the most innovative change makers in biotech and honored to have the opportunity to amplify their success! We know how hard they've been working behind the scenes! Cheers to Piraye Beim and the entire Celmatix team! CC: Advanced Research Projects Agency for Health (ARPA-H) G2G - Innovative Government Affairs Consulting
-
Have you seen Justin Williams, M.S. latest article in MedCity News? https://lnkd.in/gievUjg4 "Over the past decade, digital health tools have seen tremendous growth, significantly enhancing patient care. The rise of technology has fostered collaboration across various fields, including biotechnology, digital health, and clinical practice, leading to more integrated and efficient healthcare systems. As these tools continue to advance, interdisciplinary collaboration will be essential in addressing complex health challenges." CC: Seae Ventures
-
What a week in NYC! We had an amazing time with the Springboard Enterprises team and community, celebrating the accomplishments of women-led businesses and supporting the next generation of innovative founders at Nasdaq! Together, we honored: Entrepreneur of the Year: Neha Sampat, CEO & Founder of Contentstack Champion of the Year: Shelley Zalis, CEO & Founder of The Female Quotient Investor of the Year: Nancy Pfund and Ira Ehrenpreis, co-founders of DBL Partners Rising Stars: Christine Masters, Contentstack; Lily Shanta Howlader, Lasa Health; Adrienne Juett, NopSec;?& Zareen Erskine, FinMkt Ft: Ariel KramerPhuong Jean Pham Cheri Ackerman Julie B. Kennedy Amanda (Curtis) Burkardt Pahini Pandya Martha Sklavos PhD, PMP Amy Urban DMD Nathalya Mamane Adrianna Cantu Julie Silverstein Peter Micca Karen Snow Becca Hurowitz Kay Koplovitz
-
Concarlo Therapeutics is pioneering a novel approach in oncology by targeting p27, the master regulator of CDK2/4/6, to halt cancer cell proliferation. Unlike traditional CDK inhibitors, Concarlo's p27 inhibitors prevent the activation of these key kinases, which play a critical role in driving tumor growth. This approach has shown promise in preclinical studies, where Concarlo’s inhibitors reduced tumor growth and extended survival. Concarlo is opening new pathways for effective cancer therapies with a focus on the potent regulation of cancer’s fundamental proliferation mechanisms. Check out Dr. Stacy Blain's article in Drug Discovery & Development to learn more:
-
We're back from HLTH USA! Congrats to Jody Tropeano Greene, Mary Sheridan, Nancy Mastroianni, Barry Edelman, Amanda Ciccatelli and team for another successful year! Proud to work with The Digital Health Hub Foundation - Digital Health Awards to honor some of the leading innovators in healthcare. It was a record year for the Digital Health Awards, with thousands of applications pouring in from companies across the globe. We also had the opportunity to .... ?? Celebrate DeepLook Medical's latest news on the HLTH News Stage (New breast ultrasound product + new data on cost savings for patients + healthcare systems! Go Marissa Fayer!) ?? Cheer on PeriGen as a Finalist at the Digital Health Awards (Keep up the great work Karen Kolega, DNP, MSN-CNL, RNC-OB, C-EFM, C-ONQS and team!) ? Watch Alice Zheng, Partner at Foreground Capital take the stage to speak on the panel "The Under-researched, Under-diagnosed and Overlooked Truth about Women's Health" with?Frederique Dame, GP at GV (Google Ventures), Marlena Fejzo, CSO at Harmonia Healthcare, and Sophia Yen, MD, MPH, Co-Founder & CMO at Pandia Health, moderated by Lucy Perez PhD, Senior Partner at McKinsey & Company. ?? Connect with other healthcare and biotech pioneers we work with, partners, friends, industry leaders, and more! #HLTH2024
-
Huge congratulations to Celmatix!!! We are so proud to partner with innovators like Piraye Beim and her team as they pave the way for a better future for women globally. Not only have they achieved a significant milestone to make fertility treatments easier but have been chosen out of thousands of companies to receive Advanced Research Projects Agency for Health (ARPA-H) funding as part of the Sprint for Women's Health! Read the full news here: Fertility Drug Program News: https://lnkd.in/gZA4pt3i ARPA-H News: https://lnkd.in/d9qCDw_6
-
Who's going to HLTH USA ???! Join us in celebrating the next generation of healthcare innovators with The Digital Health Hub Foundation - Digital Health Awards on Oct 21st at Milos in the The Venetian Resort Las Vegas (we're almost at capacity!) ? https://lnkd.in/d9S4Ccka Enjoy an open bar, gourmet food, beats from a top Vegas DJ and more! Full schedule: Monday, October 21st ? Rising Star Grand Finale ?? 1-2pm PST - Pavilion Awards Stage (Booth #3254) ?? Headline Grand Finale ??? 5-6pm PST - Disco Stage ?? After Party ?? 6-9pm PST - Milo's in the Venetian We're excited to be there with many of the pioneering companies we work with innovating healthcare, partners, friends, and more! See you soon!
-
Great week in Boston! It was a pleasure to be able to get together with so many of my favorite people innovating in healthcare and biotech. Thank you everyone for all the great conversations and many thanks to those who came to my PR roundtable at #WHIS2024. It was an honor to highlight the work we’re doing and to showcase the incredible impact the companies we work with are making, from early cancer detection and health equity to advancements in contraception, ovarian health, the use of AI to improve patient outcomes, and more. These past few days flew by but but as always, connecting in person really can't be beat. Special congrats to Alice Zheng, Elizabeth Bailey, and Stasia Obremskey on announcing the launch of Foreground Capital! For those of you going to HLTH USA in a few weeks..see you in Vegas! Ft: Oriana Papin-Zoghbi AOA Dx Kevin Eisenfrats Contraline Piraye Beim Celmatix Nathan Lee WhiteLab Genomics Liz Powell Katie Collins Madeline Stickley G2G - Innovative Government Affairs Consulting Linda Greub, CFA, MBA Avestria Ventures Justin Williams, M.S. Seae Ventures Nada (Osman) Hanafi Sunday Daniels, MBA, CLC, NP Center for Black Maternal Health and Reproductive Justice at Tufts University Bayer Bayer Co.Lab
-
DeepLook Medical just hit two major milestones! "Along with the funding announcement, DeepLook has released new data showcasing the impact of DL Precise at a major New York hospital. According to the data, the hospital saw a 12% improvement in recall rates, improving adherence to the American College of Radiology (ACR) guidelines for breast cancer detection. The technology also contributed to the detection of a previously undiagnosed cancer, highlighting its potential to significantly improve diagnostic accuracy and patient outcomes." “DL Precise marks a significant advancement in medical imaging technology, positioning DeepLook at the forefront of innovation,” said Michael Shufeldt, MBA, Principal at Xcellerant Ventures. “We believe this technology has the potential to redefine how healthcare providers approach breast cancer detection, particularly in cases where clarity and precision are most needed.” Congratulations Marissa Fayer and team!
DeepLook Medical Announces First Close of Series A Funding Round; Releases Promising Data on Cancer Detection Technology
https://femtechinsider.com